Quinacrine

DRUG4 trials

Sponsors

Medical Research Council, University of California, San Francisco, Cleveland BioLabs

Conditions

Creutzfeldt-Jakob DiseasePrion DiseaseProstatic CancerRenal Cell Carcinoma

Phase 2

CJD (Creutzfeldt-Jakob Disease) Quinacrine Study

CompletedNCT00183092

University of California, San FranciscoCreutzfeldt-Jakob Disease

Start: 2005-04-30End: 2012-06-30Updated: 2014-06-09

Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer

CompletedNCT00417274

Cleveland BioLabsProstatic Cancer

Start: 2006-12-31End: 2008-05-31Updated: 2013-04-11

Treatment of Advanced Renal Cell Carcinoma With Quinacrine

WithdrawnNCT00574483

Cleveland BioLabsRenal Cell Carcinoma

Start: 2007-11-30End: 2008-01-31Updated: 2015-08-03

Unknown Phase

PRION-1: Quinacrine for Human Prion Disease

CompletedNCT00104663

Medical Research CouncilPrion Disease

Start: 2004-06-30End: 2007-03-31Target: 160Updated: 2015-04-07

Related Papers

Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease.

2013-10-1196 citations